J Gynecol Oncol | Volume 3, Issue 4 | Case Report | Open Access
Anthony C1, Michael A1, Mary F1* and Mirna M2
1Department of Obstetrics and Gynecology, Nassau University Medical Center, USA
2American University of the Caribbean School of Medicine, USA
*Correspondance to: Mary Fatehi
Fulltext PDFObjective: Ovarian cancer represents the second most common gynecologic malignancy after endometrial cancer and carries the highest mortality of all female cancers at fifty percent. With no adequate early-detection screening options to identify ovarian cancer in patients, research is ongoing. Screening modalities in addition to history and physical examination currently include imaging, usually with vaginal sonography, and tumor markers, serum proteins and biomarkers used for screening, diagnosis, prognosis and monitoring effectiveness of treatment. Methods: We report a case of an intestinal-type mucinous borderline ovarian tumor, showing as a heterogeneous complex cystic mass with curvilinear anechoic and echogenic areas on transvaginal sonogram, with an abnormally elevated serum Carcinoembryonic Antigen (CEA) level. Results: In this case, transvaginal ultrasound was able to accurately show the components of the tumor. Additional diagnostic imaging and colonoscopy in the setting of elevated tumor markers confirmed the absence of associated malignancy. The ovarian tumor was successfully removed surgically laparoscopically with fertility sparing unilateral adnexectomy. Conclusion: Literature review indicates clinical benefit of CEA among other ovarian tumor markers in determining the presence and type of tubo-ovarian malignancy prior to recommended surgical intervention.
Ovarian neoplasms; Carcinoma; Ovarian epithelial; Biomarkers; Tumor; CA-125 Antigen; Carcinoembryonic antigen
Anthony C, Michael A, Mary F, Mirna M. Case Report: Elevated Tumor Markers in Ovarian Low Malignant Potential Tumors. J Gynecol Oncol. 2020; 3(4): 1037.